Wednesday, May 5, 2010
As reported in the Drug Recall Lawyer Blog: CNN reports on the Tylenol recall and the FDA's investigation into the quality control issues and security lapses at Johnson & Johnson's Pennsylvania manufacturing facility. An FDA representative has stated "This is yet another example of when a company has to take full accountability for the quality of its drugs [with] severe consequences for not doing so." As new evidence comes to light, it appears that Johnson & Johnson has not timely addressed customer complaints since June 2009 about foreign substances in the medicine. Here's a link to the FDA's press release, and a link to the 17-page FDA plant inspection report.